Jennifer Lew
Director of Finance/CFO at ANNEXON, INC.
Net worth: 588 356 $ as of 2024-03-30
Profile
Jennifer Lew is currently an Independent Director at Boundless Bio, Inc. and the Chief Financial Officer & Executive Vice President at Annexon, Inc. She previously worked as a Finance Director & Assistant Controller at QRS Corp.
from 2000 to 2004, an Audit Manager at Ernst & Young LLP from 1994 to 1999, the VP, Chief Financial & Accounting Officer at Dynavax Technologies Corp.
in 2013, and the Chief Financial & Accounting Officer at Aduro BioTech, Inc. from 2013 to 2019.
Ms. Lew obtained her undergraduate degree from Claremont McKenna College in 1994.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ANNEXON, INC.
0.09% | 2024-02-19 | 82,058 ( 0.09% ) | 588 356 $ | 2024-03-30 |
BOUNDLESS BIO INC.
-.--% | 2024-03-27 | 0 ( -.--% ) | - $ | 2024-03-30 |
Jennifer Lew active positions
| Companies | Position | Start |
|---|---|---|
| ANNEXON, INC. | Director of Finance/CFO | 2019-05-31 |
| BOUNDLESS BIO, INC. | Director/Board Member | 2022-01-04 |
Former positions of Jennifer Lew
| Companies | Position | End |
|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Director of Finance/CFO | 2019-05-23 |
| DYNAVAX TECHNOLOGIES CORPORATION | Director of Finance/CFO | 2013-10-14 |
QRS Corp.
 QRS Corp. Internet Software/ServicesTechnology Services QRS Corp. provide electronic commerce merchandising and logistics solutions. The services include catalog services, network services, inventory management services, logistics management services and professional services. The company is headquartered in Richmond, CA. | Director of Finance/CFO | 2003-12-31 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 1998-12-31 |
Training of Jennifer Lew
| Claremont McKenna College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| DYNAVAX TECHNOLOGIES CORPORATION | Health Technology |
| ANNEXON, INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| Private companies | 3 |
|---|---|
QRS Corp.
QRS Corp. Internet Software/ServicesTechnology Services QRS Corp. provide electronic commerce merchandising and logistics solutions. The services include catalog services, network services, inventory management services, logistics management services and professional services. The company is headquartered in Richmond, CA. | Technology Services |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
- Stock Market
- Insiders
- Jennifer Lew
